MISSY WU: Open Payments
NPI 1154957751 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 28 payments from 12 companies in 2025. Trend: 2023 $169 · 2024 $1,269 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Alkermes, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $21 |
Products named: SPRAVATO, FANAPT, CAPLYTA, TRINTELLIX, Auvelity, REXULTI, ARISTADA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
